4.6 Review

From the Sea to Anticancer Therapy

Journal

CURRENT MEDICINAL CHEMISTRY
Volume 18, Issue 23, Pages 3551-3562

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/092986711796642652

Keywords

Anti-cancer therapy; clinical trial; FDA-approval; EMEA-approval; marine compound; mechanism of action; pre-clinical trial; synthetic compound

Ask authors/readers for more resources

Discovery, isolation, characterisation and pre-clinical and clinical trials of plant-or animal-derived drugs displaying pharmacological activities continue to develop and enlarge. Cancer chemotherapy is one of the most promising areas for these drugs. Since a very long time, nature has been an attractive source of potential medicinal agents for human use. The deep sea is becoming a novel and potently appealing source for new drugs, as well as shallow waters. This interest is mainly related to the terrific chemical diversity found in the vast number of plants and animal species, as well as in the microbial world. During the evolution, a rich source of biologically active compounds is developed in the depths of the sea, often reflecting ecological adaptation. Most of them (toxins) are developed to allow survival and flourishing acting against predators and parasites. Recent progress in Scuba diving, hitech/biotechnological and procedural advances in structure clarification, organic synthesis and biological assay determined the characterisation and preclinical/clinical evaluation of novel anticancer drugs. The aim of this review is to provide a description of their discovery, mode of action and clinical application.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available